Position in JNJ
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$9,378,096
+$741,298 QoQ
Shares Held
36,926
+4.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.37%
of 13F equity value
Holder Rank
#1,150
of 4,664 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Legacy Advisors, LLC holds $21,307,408 across 9 Drug Manufacturers - General names. JNJ ranks #1 (44.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
36,926 | $9,378,096 | |
| 2 | ABBV |
AbbVie Inc.
|
16,549 | $4,164,390 | |
| 3 | LLY |
ELI LILLY & Co
|
2,152 | $2,581,173 | |
| 4 | AMGN |
Amgen Inc
|
4,387 | $1,588,620 | |
| 5 | MRK |
Merck & Co., Inc.
|
11,408 | $1,465,928 | |
| 6 | PFE |
Pfizer Inc
|
40,590 | $977,407 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
8,051 | $463,898 | |
| 8 | NVS |
Novartis AG
|
2,837 | $444,614 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,378,096 | 36,926 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $8,636,798 | 35,333 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $6,969,455 | 33,677 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $5,995,741 | 32,336 | Shares | Sole | 2025-11-13 | |
| 2025-03-31 | $8,656,516 | 52,198 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $7,981,433 | 55,189 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,935,088 | 61,305 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $8,632,794 | 59,064 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $9,506,744 | 60,097 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $10,219,761 | 65,202 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $11,302,933 | 72,571 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $11,303,691 | 68,292 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $8,666,205 | 55,911 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $9,655,689 | 54,660 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $8,064,756 | 49,368 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $8,316,521 | 46,851 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $7,484,600 | 42,231 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $3,191,824 | 18,658 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,992,272 | 18,528 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $3,023,637 | 18,354 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $3,142,865 | 19,123 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $2,936,238 | 18,657 | Shares | Sole | 2021-01-15 | |
| 2020-09-30 | $2,807,727 | 18,859 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $2,594,342 | 18,448 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $3,028,971 | 23,099 | Shares | Sole | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||